Poolbeg Pharma plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Cathal Friel, was filed 25 Jun 2025.
Poolbeg Pharma plc: what insiders have been doing
This page follows insider dealings at Poolbeg Pharma plc as filed with RNS (LSE), a company from the Health Care sector. No insider at Poolbeg Pharma plc has published a filing in the past twelve months. The most recent one dates from 25 June 2025.
The full history, which starts in 2024, counts 2 purchases against no sales.
For comparison within the same sector, see the insider buying recorded at Vivos Inc and Anixa Biosciences Inc. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +110.9%Entry £0.03 · Close at T+365 £0.07
- -62.6%Entry £0.10 · Close at T+365 £0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Poolbeg Pharma plc Strong Buy (bullish), based on 1 analysts. Average price target: £0.19.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,000,000 shares@ £0.025100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BKPG7Z60RNS:5710117Canonical exit: 23 Sept 2025 (T+90)
- 154,764 shares@ £0.108100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BKPG7Z60RNS:5076158Canonical exit: 21 May 2024 (T+90)
2 of 2 declarations
About Poolbeg Pharma plc
Poolbeg Pharma plc is a biopharmaceutical company focused on developing treatments for infectious diseases. It utilizes a drug discovery platform to identify and develop therapeutic candidates.
